# Aireen

> EU-MDR Class IIb certified autonomous AI that detects serious eye and chronic diseases from a retina scan in seconds — no specialist review required.

Aireen is a certified medical device company building autonomous AI for retinal screening at population scale. Our software analyzes standard 45° fundus images to screen for diabetic retinopathy and age-related macular degeneration today, with cardiovascular risk indications in clinical development.

## Pages

- [Home](/): Autonomous AI retinal screening — company overview, key clinical outcomes, target audiences.
- [Diagnostics](/product/diagnostics): Validated AI modules for diabetic retinopathy, AMD, and cardiovascular risk pipeline.
- [Technology](/product/technology): Hardware-agnostic architecture, DICOM/PACS-native workflows, ISO 27001 governance.
- [Science](/company/science): Multi-center clinical trial data, sensitivity/specificity results, scientific advisory panel.
- [About us](/company/about-us): Mission, executive team, and global vision to screen one million patients.
- [Support](/support): Official Instructions for Use in multiple languages and remote-support instructions.

## Czech version (cs)

- [Domů](/cs): Autonomní AI pro screening retiny — přehled společnosti a klíčové klinické výsledky.
- [Diagnostika](/cs/produkt/diagnostika): Validované AI moduly pro diabetickou retinopatii, VPMD a kardiovaskulární riziko.
- [Technologie](/cs/produkt/technologie): Architektura nezávislá na hardwaru, DICOM/PACS workflow, ISO 27001.
- [Věda](/cs/spolecnost/veda): Data z multicentrických klinických studií a vědecká rada.
- [O nás](/cs/spolecnost/o-nas): Mise, vedení a globální vize.
- [Podpora](/cs/podpora): Návody k použití a vzdálená podpora.

Czech pages are intended for healthcare professionals and are gated by a
professional-audience confirmation required by Czech law (§ 2a zákona č. 40/1995 Sb.).